News

High Court upholds NICE decision to limit treatments for Alzheimer's disease

BMJ 2007; 335 doi: 10.1136/bmj.39307.630347.DB (Published 16 August 2007)
Cite this as: BMJ 2007;335:319.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Owen Dyer
  1. London

    Campaigners and drug makers failed last week in their High Court bid to overturn guidance recommending only limited coverage on the NHS of drugs to treat Alzheimer's disease. This was the first major legal challenge to guidance issued by the National Institute for Health and Clinical Excellence (NICE), the body that recommends which drugs are available on the NHS in England and Wales.

    Mrs Justice Dobbs ordered NICE to amend the existing guidance, having ruled that its diagnostic criteria breached the Disability Discrimination Act and the Race Relations Act. NICE undertook to make the relevant changes within 28 days—but the core of the guidance will remain unchanged.

    The guidance recommends …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular